These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12072810)

  • 1. Concordance as well as discordance for congenital malformations in valproate-exposed half-siblings with parental consanguinity may indicate a specific gene-teratogen interaction.
    ten Berg K; Lindhout D
    Clin Dysmorphol; 2002 Jul; 11(3):227-8; author reply 229-30. PubMed ID: 12072810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment: valproate dose effects differ across congenital malformations.
    Meador KJ
    Neurology; 2013 Sep; 81(11):1002. PubMed ID: 23911754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability.
    Clayton-Smith J; Bromley R; Dean J; Journel H; Odent S; Wood A; Williams J; Cuthbert V; Hackett L; Aslam N; Malm H; James G; Westbom L; Day R; Ladusans E; Jackson A; Bruce I; Walker R; Sidhu S; Dyer C; Ashworth J; Hindley D; Diaz GA; Rawson M; Turnpenny P
    Orphanet J Rare Dis; 2019 Jul; 14(1):180. PubMed ID: 31324220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Split-hand/split-foot malformation associated with maternal valproate consumption.
    Sukumaran S; Krishnamoorthy T; Thomas SV
    Neurol India; 2005 Jun; 53(2):251-2. PubMed ID: 16010085
    [No Abstract]   [Full Text] [Related]  

  • 5. Lung hypoplasia--a possible teratogenic effect of valproate. Case report.
    Janas MS; Arrøe M; Hansen SH; Graem N
    APMIS; 1998 Feb; 106(2):300-4. PubMed ID: 9531963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. France bans sodium valproate use in case of pregnancy.
    Casassus B
    Lancet; 2017 Jul; 390(10091):217. PubMed ID: 28721869
    [No Abstract]   [Full Text] [Related]  

  • 7. A male with fetal valproate syndrome and autism.
    Williams PG; Hersh JH
    Dev Med Child Neurol; 1997 Sep; 39(9):632-4. PubMed ID: 9344057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teratogenesis of sodium valproate.
    Duncan S
    Curr Opin Neurol; 2007 Apr; 20(2):175-80. PubMed ID: 17351488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproate and the risk for congenital malformations: Is formulation and dosage regime important?
    Mawhinney E; Campbell J; Craig J; Russell A; Smithson W; Parsons L; Robertson I; Irwin B; Morrison P; Liggan B; Delanty N; Hunt S; Morrow J
    Seizure; 2012 Apr; 21(3):215-8. PubMed ID: 22364656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The U.S. Food and Drug Adminstration (FDA) has assigned pregnancy category D to valproate.
    Peckman H
    N C Med J; 2010; 71(4):396-8. PubMed ID: 21155112
    [No Abstract]   [Full Text] [Related]  

  • 11. Low serum concentration of all-trans and 13-cis retinoic acids in patients treated with phenytoin, carbamazepine and valproate. Possible relation to teratogenicity.
    Fex G; Larsson K; Andersson A; Berggren-Söderlund M
    Arch Toxicol; 1995; 69(8):572-4. PubMed ID: 8534203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal valproate embryopathy in twins: genetic modification of the response to a teratogen.
    Hockey A; Bower C; Goldblatt J; Knowles S
    Birth Defects Orig Artic Ser; 1996; 30(1):401-5. PubMed ID: 9125345
    [No Abstract]   [Full Text] [Related]  

  • 13. The emerging story of Sodium Valproate in British newspapers- A qualitative analysis of newspaper reporting.
    Siriwardena S; McAllister N; Islam S; Craig J; Kinney M
    Seizure; 2022 Oct; 101():127-133. PubMed ID: 35973301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate: a simple chemical with so much to offer.
    Peterson GM; Naunton M
    J Clin Pharm Ther; 2005 Oct; 30(5):417-21. PubMed ID: 16164485
    [No Abstract]   [Full Text] [Related]  

  • 15. [Embryopathy due to valproic acid with severe malformations in the central nervous system].
    Pardal-Fernández JM; Carrascosa-Romero MC; Rodríguez-Vázquez M; Marco-Giner J; Martínez-Gutiérrez A
    Rev Neurol; 2006 Mar 16-31; 42(6):336-40. PubMed ID: 16575769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early intervention for the ocular and neurodevelopmental sequelae of Fetal Valproate Syndrome.
    Carrim ZI; McKay L; Sidiki SS; Lavy TE
    J Paediatr Child Health; 2007 Sep; 43(9):643-5. PubMed ID: 17688650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal valproate dosage and foetal malformations.
    Vajda FJ; Eadie MJ
    Acta Neurol Scand; 2005 Sep; 112(3):137-43. PubMed ID: 16097954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Example of teratogen detection using a birth defects registry: depakine and spina bifida].
    Robert E
    Rev Epidemiol Sante Publique; 1996; 44 Suppl 1():S78-81. PubMed ID: 8935868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is carbamazepine a human teratogen?
    Vajda FJE; O'Brien TJ; Graham J; Lander CM; Eadie MJ
    J Clin Neurosci; 2016 Jan; 23():34-37. PubMed ID: 26521756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teratogen update: valproic acid.
    Lammer EJ; Sever LE; Oakley GP
    Teratology; 1987 Jun; 35(3):465-73. PubMed ID: 3114906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.